Page 9 - Haematologica3
P. 9
Table of Contents
Volume 103, Issue 3: March 2018
Cover Figure
haematologica Journal of the European Hematology Association
Published by the Ferrata Storti Foundation
Bone marrow smear showing increased erythropoietic activity, large cell size, nucleus-cytoplasmic asynchrony, and nuclear chromatin more open than expected in a patient with vitamin B12 deficiency. Courtesy of Prof. Rosangela Invernizzi.
Editorials
375 Can we forecast induction failure in acute myeloid leukemia? Felicitas Thol
377 Bortezomib for prevention of acute graft-versus-host disease: a conclusion reached Paul J. Martin
379 Use of desmopressin in the treatment of hemophilia A: towards a golden jubilee Pier Mannuccio Mannucci
Review Article
382 Extracellular vesicles in the hematopoietic microenvironment John T. Butler et al.
Articles
Hematopoiesis
395 Glucocorticoids induce differentiation of monocytes towards macrophages that share functional and phenotypical aspects with erythroblastic island macrophages
Esther Heideveld et al.
Red Cell Biology & Its Disorders
406 miR-144/451 represses the LKB1/AMPK/mTOR pathway to promote red cell precursor survival during recovery from acute anemia Xiao Fang et al.
Bone Marrow Failure
417 Hypomorphic FANCA mutations correlate with mild mitochondrial and clinical phenotype in Fanconi anemia Roberta Bottega et al.
Myelodysplastic Syndromes
427 Constitutional SAMD9L mutations cause familial myelodysplastic syndrome and transient monosomy 7 Victor B. Pastor et al.
Chronic Myeloid Leukemia
447 CD36 defines primitive chronic myeloid leukemia cells less responsive to imatinib but vulnerable to antibody-based therapeutic targeting Niklas Landberg et al.
Acute Myeloid Leukemia
456 A 29-gene and cytogenetic score for the prediction of resistance to induction treatment in acute myeloid leukemia Tobias Herold et al.
Myeloproliferative Neoplasms
438 Benefits and pitfalls of pegylated interferon-α2a therapy in patients with myeloproliferative neoplasm-associated myelofibrosis: a French Intergroup of Myeloproliferative neoplasms (FIM) study
Jean-Christophe Ianotto et al.
Haematologica 2018; vol. 103 no. 3 - March 2018 http://www.haematologica.org/
